James Basta, EVP, General Counsel at Intellia Therapeutics, Inc. (NTLA), sold 1,138 shares at $37.21 ($42K) on 2023-01-04, disclosed to the SEC on 2023-01-06.
Open-market sale of $42k NTLA by EVP, General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NTLA | SELL | 2025-03-04 | $23K | — | Filing → |
| NTLA | SELL | 2025-01-07 | $172K | — | Filing → |
| NTLA | SELL | 2024-03-05 | $152K | — | Filing → |